Eye-minders
Products to Enhance Safety and Based on Eye-movement Analysis.
Company Overview
Snapshot
Founded in October 2017 by Daphna Palti-Wasserman, Eye-minders operates with 1–10 employees. The company has raised $5.8 million across one funding round from one investor. Eye-minders is expanding into clinical mental health, building on its established credibility assessment product.
Business overview
Eye-minders is a deep-tech company that develops patented AI algorithms to analyze eye movements and pupil dynamics, extracting biomarkers for cognitive and emotional load. Its core technology is applied in a commercial product for credibility assessment, currently utilized by private companies and government agencies. The company is expanding its focus into clinical mental health, with initiatives such as a PTSD diagnostics pilot in collaboration with leading hospitals. Eye-minders operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare, Digital Medical Diagnostics, and Digital Therapeutics, serving both healthcare providers and consumers.
Strategic signal
In March 2024, Eye-minders was featured in CTech for its innovative approach to understanding a person's inner world through eye analysis. This highlights the company's progress in leveraging its patented AI algorithms for broader applications beyond its initial credibility assessment product, signaling potential for significant impact in mental health diagnostics and a strong validation of its deep-tech capabilities.
Log in to access full profile ›Company Intelligence Q&A
- What is Eye-minders' core technology?
- Eye-minders develops patented AI algorithms that analyze eye movements and pupil dynamics to extract biomarkers of cognitive and emotional load.
- When was Eye-minders founded?
- Eye-minders was founded in October 2017.
- What is Eye-minders' primary sector?
- Eye-minders' primary sector is Health Tech & Life Sciences, with a focus on Digital Healthcare, Digital Medical Diagnostics, and Digital Therapeutics.
- What is Eye-minders' current focus in clinical applications?
- Eye-minders is expanding into clinical mental health, including a PTSD diagnostics pilot in collaboration with leading hospitals like Sheba Medical Center, selected by MAFAAT (Israel’s Directorate of Defense R&D).
- What is the total funding raised by Eye-minders?
- Eye-minders has raised a total of $5.8 million across one funding round. The company's last funding round was a Series A.